1.Competitive price
2.Fast Delivery Within 2 days
3.SGS , BV, GMP,ISO approve
4.Professional factory
$31.20 - $31.40 / Kilogram
Hydroxyurea is a nucleoside diphosphate reductase inhibitor, can prevent the nucleotidereduced to deoxy nucleotides, purine and pyrimidine bases interfere with the biosynthesis, selectively impede DNA synthesis, RNA and protein synthesis on the role of non-blocking.
| product Name | Hydroxyurea |
|---|---|
| Synonyms | Hydroxycarbamide; 1-hydroxyurea; Biosupressin; sq 1089; wr 83799; Carbamohydroxamic acid; Carbamohydroximic acid; Carbamoyl oxime; Carbamyl hydroxamate; Hidrix; Hidroxicarbamida; HU; Hydrea; Hydreia; Hydroxycarbamine; Hydroxylurea; hydroxy urea (d4); Hydura; Hydurea; Litaler; Litalir; N-(aminocarbonyl)hydroxylamine; N-Carbamoylhydroxylamine; N-Hydroxyurea; Onco-carbide; Oxyurea; sk 22591; Hydroxy urea; amino(oxido-λ5-azanyl)methanone |
| Molecular Formula | CH4N2O2 |
| Molecular Weight | 76.0547 |
| InChI | InChI=1/CH4N2O2/c2-1(4)3-5/h3H2,(H2,2,4) |
| CAS Registry Number | 127-07-1 |
| EINECS | 204-821-7 |
| Water solubility | soluble |
| Density | 1.733g/cm3 |
| Melting point | 142-146°C |
| Refractive index | 1.543 |
For malignant melanoma, gastric cancer, colon cancer, breast cancer, bladder cancer, head and neck cancer, malignant lymphoma, primary liver cancer and acute, chronic myeloid leukemia. Combined with radiotherapy and chemotherapy, brain tumor was treated.
